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Background: Oral lichen planus (OLP) is a chronic inflammatory disease mediated by T cells, which manifests as 
reticular (white) or erosive (red) lesions, that are eventually painful. Oral lichenoid lesion (OLL) are distinguished 
from OLP by the presence of precipitating factors. The aim of this study was to evaluate whether the presence of 
metallothionein, which is involved in anti-apoptotic pathways and the anti-oxidative response, could serve as a 
differential diagnostic for OLP and OLL. 
Material and Methods: We evaluated the expression of metallothionein in 40 cases of OLP and 20 cases of OLL 
using immunohistochemistry. 
Results and Conclusions: White OLP has higher concentrations of metallothionein than red OLP in basal and 
parabasal layers. Moreover, metallothionein was more frequently observed in the cytoplasm and nuclei of basal 
cells in OLP patients compared to the same regions of OLL cases. Metallothionein levels are related to OLP sever-
ity and may contribute to a differential diagnosis between OLP and OLL.
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Introduction
Oral lichen planus (OLP) is a chronic autoimmune dis-
ease of the oral mucosa, mediated by T lymphocytes 
(1-4). It is found in up to 2% of adults, more frequent-
ly in women, in the fifth to sixth decades of life (1-4). 
Typically, OLP manifests bilaterally in tongue and/or 
buccal mucosa, as white striae or plaques with striated 
borders. Some cases occur as atrophic or ulcerated le-
sions, intermingled with white striae and plaques. Rare 
forms are associated with formation of bullae. Accord-
ing to clinical presentation, OLP has been classified into 
white (also described as keratotic or reticular/plaque 
like forms) or red lesions (also described as atrophic/
erosive) (1-4). White forms are usually asymptomatic, 
but red lesions often result in pain or a burning sensa-
tion with significant discomfort to the patient (1-4). 
Histologically, OLP is characterized by the presence of 
a distinct band-like zone of lymphocytic infiltration that 
is confined to the superficial (juxta-epithelial) aspect of 
the connective tissue, accompanied by epithelial altera-
tions such as degeneration, necrosis, and apoptosis of 
basal cells (1-4). In the white form of OLP, the overly-
ing epithelium responds to immunological aggression 
with hyperkeratosis, while atrophy or ulceration results 
in the red lesions. Epithelial dysplasia is not expected 
and, in fact, it has been advocated that lesions with his-
topathological features of OLP that present epithelial 
dysplasia should be considered as pathological entities 
distinct from OLP (1-4).
Oral lichenoid lesion (OLL) is another common im-
mune-mediated disease of the oral mucosa (1-4). It 
shares the clinical presentation of OLP, with striae, 
plaques, and eventual epithelial atrophy or ulcer (1-4). 
In most cases, there is an exposition to a precipitating 
factor such as medications or dental materials. Single 
or unilateral lesions, and deep perivascular or mixed 
infiltrate of inflammatory cells are also typical, but not 
always present, in OLL cases (1-4). The distinction be-
tween OLP and OLL is often a dilemma for clinicians 
and pathologists. Besides, the precise etiopathogenesis 
of OLP and OLL are still unknown. 
Metallothionein (MT) is a family of four non-enzymat-
ic proteins that provide an intracellular reservoir for 
zinc, protect cells from toxic heavy metals and oxida-
tive stress, and participate in the regulation of cellular 
proliferation and differentiation (5-9). Also, MT influ-
ences the immune response, probably with chemotactic 
or regulatory/suppressive roles (5-10). 
Allon et al. described MT expression in the lowest 
layers of the oral epithelium and in the inflammatory 
infiltrate of OLP-affected patients (11). Higher MT ex-
pression has been observed in hyperkeratotic (white) 
rather than in atrophic/erosive (red) lesions of OLP, pre-
sumably due to the more pronounced anti-apoptotic re-
sponse in reticular forms of the disease (11). In contrast, 
amalgam, which is one of the most frequent precipitat-
ing factors for OLL, can stimulate MT expression (12). 
However, no other previous study has investigated the 
expression of this protein in OLL, or directly compared 
MT levels in OLP and OLL. Taken into account these 
paucities, the aim of this study was to explore the im-
munohistochemical reactivity for MT in OLP and OLL, 
to improve our understanding of the pathogenesis of 
these diseases and to determine whether MT can serve 
as a differential diagnostic between OLP and OLL.
Material and Methods 
-Patients
This study was approved by the Institutional Commit-
tee for Ethics on Research.  Forty cases of OLP and 
twenty OLL associated to amalgam dental fillings were 
reviewed following Van der Meij and Van der Waal di-
agnostic criteria (4).  Furthermore, cases of OLP were 
then segregated into two distinct groups according to 
the clinical presentation of the disease as proposed by 
Ismail et al. (3): reticular and hyperplastic forms, were 
called white OLP, n=24; and atrophic and erosive forms, 
were called red OLP, n=16. Data concerning age, gen-
der, ethnicity, primary site, number of lesions, symp-
toms and symptom duration was retrieved from dental 
files.
-Immunohistochemical data
Immunohistochemical assays were performed on 3mm 
thick tissue sections using the streptavidin-biotin-
peroxidase method according to standard protocols. 
After deparaffinization and hydration, sections were 
subjected to antigen retrieval using EDTA+Tween 20 
buffer (pH=8.0) in a decloaking chamber (Biocare 
Medical, Concord, CA, USA) for 15 minutes at 110°C. 
Endogenous avidin and biotin binding activities were 
blocked using skim milk and white eggs. Endogenous 
peroxidase activity was blocked using three washes of 
3% H2O2, each 10 minutes in duration. Incubation with 
a protein block solution for 15 minutes at room tem-
perature was performed to prevent nonspecific binding 
(Starr Trek Universal HRP Detection System, Biocare 
Medical). The sections were incubated with monoclonal 
mouse anti-metallothionein antibody (clone E9, Dako 
North America Inc., Carpinteria, CA, USA) at a dilution 
of 1:400, in a humid chamber at 25°C for 2 hours. Sig-
nal amplification and staining were developed using the 
Starr Trek Universal HRP Detection System (Biocare 
Medical), and then the sections were counterstained 
with Harris hematoxylin. As a negative control, prima-
ry antibodies were replaced with phosphate-buffered 
saline. Samples of hepatocellular carcinomas were used 
as positive controls, controls based on manufacturer’s 
guidelines.
-Immunostaining evaluation
Evaluation of the immunohistochemical staining was 
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performed with an optical microscope by two investiga-
tors (G.G.M. and C.S.S.) using the Quickscore method 
(13). Briefly, for each epithelial layer of each case the 
proportion of stained (positive) epithelial cells through-
out the section was scored from one to six (1: 0-4%; 
2: 5%-19%; 3: 20%-39%; 4: 40%-59%; 5: 60%-79%; 6: 
80%-100%). The intensity of staining was also scored 
from zero to three, corresponding to the presence of 
negative, weak, intermediate, or strong staining, re-
spectively. The product of scores attributed to propor-
tion and intensity of staining was the final quickscore. 
Quickscore were given only to distinctive areas of each 
sub-group. For example, in the white-OLP group only 
keratinized and acanthotic epithelial areas were ana-
lyzed. And, for the red-OLP, just atrophic epitheliums 
were examined.
-Statistical analysis
Median quickscore values between OLP and OLL, as 
well as between white and red OLP samples were com-
pared with the Mann-Whitney U test. P values < 0.05 
were considered significant. Statistical analysis was 
performed using GraphPad Prism 5 software (Graph-
Pad Software, version 5.01, San Diego, CA).
Results
-Clinic-pathological data
As shown in Table 1, most of the patients were white 
women, in their fifth decade of life. Buccal mucosa was 
the most frequent site of involvement. All cases of white 
OLP was asymptomatic, while pain or burning were re-
ported for all cases of red OLP and in 40% of OLL. 
Most of OLL lesions were clinically described as white 
lesions, only four OLL were described as red-white 
mixed lesions. Representative pictures of the clinical 
aspect of these lesions are shown in Figure 1. 
Clinical features OLP (n = 40) OLP White (n 
= 24)
OLP Red (n = 16) OLL (n = 20)
Mean age (years) 45.8±14.1 43.5 ±15.8 48.7 ±11.5 52.0 ±10.8
Male:Female ratio 1:3.6 1:3.8 1:2.7 1:3.3
White:Non-white 
ratio
1:0.35 1:0.33 1:0.37 1:0.4








Number of sites 
involved
2 (52.5%); 3 or more 
(47.5%)
Two or more 
(100%)
Two or more 
(100%)
Only one (100%)
Symptoms* 40% 0% 100% 40%
Mean complaning 
time (months)
13.2 ±18.4 20.6 ±24.7 6.9 ±8.8 8.6 ±7.2
Table 1: Clinical features of the patients enrolled in the study.
*Described as pain, burning or discomfort.
Fig. 1: Common clinical aspects observed in the 
white (A) and red (B) forms of oral lichen planus, 
as well as in oral lichenoid lesions (C).
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-Immunohistochemical data
The immunohistochemical reactivity for MT was ob-
served as cytoplasmic and nuclear staining of varied in-
tensity, depicting a mosaic pattern. In all groups, stain-
ing was more intense in the cells of the basal epithelial 
layer and was gradually less evident in upper layers. 
Figure 2 illustrates representative staining patterns for 
each group. As expected, MT reactivity was more in-
tense in the white forms of OLP when compared to the 
red ones (Table 2 and Fig. 3A to 3D). Finally, lesions of 
OLP depicted significantly higher MT reactivity than 
OLL (Table 3 and Fig. 3E and 3F). There was no differ-
ence in the MT expression in white OLL and red-white 
mixed OLL.
Fig. 2: Staining pattern commonly evidenced in the white (A and 
B) and red (C and D) forms of lichen planus, as well as oral lichen-
oid lesion (E and F). The MT immunohistochemical reactivity was 
observed as cytoplasmic and nuclear staining of the cells in the 
basal layer. This stain was gradually less evident in upper layers.
Discussion
In 1978, the World Health Organization (WHO) pro-
posed a clinical and histopathological definition for 
OLP to facilitate its recognition and differentiation 
from pre-cancerous disorders (14). This publication has 
been applied as the golden standard criteria for OLP di-
agnosis for at least 25 years. However, subsequent stud-
ies concluded that this classification has unsatisfactory 
inter- and intra-observer variability (4,14-18). This in-
consistency may be partially explained by the difficulty 
in separating OLP from several other diseases such as 
OLL or even lupus erythematosus.
To overcome this problem, Van der Meij and Van der 
Waal in 2003 proposed a set of revised diagnostic cri-
teria of OLP and OLL, including clinical as well as 
histopathological aspects (4). This new classification 
demonstrated less inter- and intra-observer variability 
and enable pathologist/researchers to perform more re-
producible diagnosis, eliminating individual diagnostic 
variation (4,18). Moreover, such data could lead to better 
clinical, pathological and etiological characterization of 
these lesions, dismissing some biases related to the in-
correct naming of these disorders. To guarantee more 
reproducible analysis, we utilized the modified WHO 
diagnostic criteria of OLP and OLL as proposed in 2003 
(4). However, such classification has some limitations, 
since these proposed criteria are not universally present 
in all OLP and/or OLL patients. 
In the present study, we observed that MT expression 
is mainly observed in basal and parabasal layers of the 
oral epithelium, as previously described (11,19,20). In 
1992, Hanada and collaborators explained that reactiv-
ity for MT in cutaneous lesions of lichen planus was 
concentrated in the granular layer of the epidermis, in 
the same way of healthy skin, but was less evident in 
the former (10). Afterwards, van den Oord and De Ley 
described the distribution of MT in normal and patho-
logical human skin (21). Although they did not include 
lichen planus in their analysis, the MT immunohisto-
chemical staining was described as strongly positive in 
basal keratinocytes of epidermis (21). Interestingly, an 
MT interrupted staining was found in the basal layer of 
interface dermatitis (21). In 1998, Matsuura, Tsukifuji, 
and Shinkai described MT expression in idiopathic an-
nular lichen planus of the skin where MT immune stain-
ing increased as well, but it was discontinuous around 
the rim of erythema and undetectable in the center of 
the lesion (19). Other authors had depicted MT positiv-
ity in lower areas of the epidermis in one case of Palmo-
plantar lichen planus (20). 
Regarding to oral lesions, it was only in 2014 that Allon 
and co-workers described that epithelial MT expression 
was significantly higher in keratotic OLP than in atro-
phic and erosive forms (11). In our work, we also ob-
served that MT expression was less evident in red than 
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Analysed areas OLP-W (n=24) OLP-R (n=16) p value*
Cytoplasmatic Cytoplasmatic
General 2.0 (0.4-6.9) 1.8 (0-3.8) 0.0992
Basal layer 8.6 (0.5-13.8) 7.6 (0-9.5) 0.0467
Parabasal layer 2.1 (0-6.6) 1.0 (0-3.7) 0.0159
Spinous layer 0.0 (0-2.2) 0.0 (0-0.3) 0.1418
Keratin layer 0.0 (0-0.20) 0.0 (0-0.4) 0.6309
Analysed areas OLP-W (n=24) OLP-R (n=16) p value*
Nucleous Nucleous
General 1.8 (0.1-7.1) 1.8 (0-3.6) 0.3774
Basal layer 8.6 (0.3-17.4) 8.3 (0-13.8) 0.3702
Parabasal layer 1.5 (0-7.4) 0.49 (0-4.1) 0.0129
Spinous layer 0.0 (0-1.1) 0.0  (0-0.2) 0.0492
Keratin layer 0.0 (0-0) 0.0 (0-0) -
Table 2: Median Quickscore in white OLP and red OLP groups. Range were presented inside parenthesis.
*Mann Whitney test; OLP-R:  oral lichen plannus - red forms; OLP-W: oral lichen plannus - white forms.
Fig. 3: (A) Comparison between the MT staining in the cytoplas-
matic compartment of the basal epithelium layer among white and 
red forms of OLP (Mann-Whitney U test, p=0.0467). (B) Compar-
ison between the MT staining in the cytoplasmatic compartment 
of the parabasal epithelium layer among white and red forms of 
OLP (Mann-Whitney U test, p=0.0159). (C) Comparison between 
the MT staining in the nuclear compartment of the parabasal epi-
thelium layer among white and red forms of OLP (Mann-Whitney 
U test, p=0.0129). (D) Comparison between the MT staining in 
the nuclear compartment of the spinous epithelium layer among 
white and red forms of OLP (Mann-Whitney U test, p= 0.0492). 
(E) Comparison between the MT staining in the cytoplasmatic 
compartment of the basal epithelium layer among OLP and OLL 
(Mann-Whitney U test, p= 0.0019). (F) Comparison between the 
MT staining in the nuclear compartment of the basal epithelium 
layer among OLP and OLL (Mann-Whitney U test, p= 0.0011).
white lesions of OLP. These results suggest that MT 
expression is related to the inflammatory pathogenesis 
of OLP. In addition, these findings validate our tech-
nique, since we were able to reproduce someone else’s 
data (11).
A previous manuscript has described the MT immuno-
localization on amalgam tattoos specimens (12). This 
paper portrayed that a weak MT positivity was usually 
seen in inflammatory and endothelial cells close re-
lated with amalgam particles (12). The authors affirm 
the presence of MT immunopositivity in the basal cell 
layer of the mucosa epithelium in all studied samples 
(12). Furthermore, MT-staining appears to be stronger 
in the epithelial basement areas impregnated with pow-
dered amalgam particles (12). Such data reinforces our 
findings, since we could also evidence a very similar 
MT immunopositivity in the basal cell layer of OLP and 
OLL samples. Taken these files together, we could as-
sume that MT expression is always upper-regulated to 
protect mucosal keratinocytes from variable sources of 
cellular stress. 
Previous studies have classified OLL in four major 
types based on the method of instigation: oral lichen-
oid lesions associated with amalgam restorations; oral 
lichenoid drug reactions; lichenoid lesions in chronic 
graft-versus-host disease, and lesions that lack an evi-
dent triggering agent but have a lichen planus like as-
pect except for one or more clinical features (1-4,22,23). 
In these lines, OLL can only be distinguished from OLP 
by two main features: 1- association with the adminis-
tration of a drug, contact with a metal (such as dental 
restorations), foodstuff or systemic disease; and 2- the 
resolution of the lesions when the causative agent is 
removed (1-4,22,23). In attempt to facilitate such seg-
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Analysed areas OLP (n=40) OLL (n=20) p value*
Cytoplasmatic Cytoplasmatic
General 1.9 (0-6.9) 1.4 (0-3.5) 0.0816
Basal layer 8.0 (0-13.8) 4.3 (0-12.6) 0.0019
Parabasal layer 1.45 (0-6.6) 1.7 (0-9.4) 0.8366
Spinous layer 0.0 (0-2.2) 0.0 (0-6.0) 0.2408
Keratin layer 0.0 (0-0.4) 0.0 (0-0.2) 0.5894
Analysed areas OLP (n=40) OLL (n=20) p value*
Nucleous Nucleous
General 1.8 (0-7.1) 1.3 (0-5.3) 0.1238
Basal layer 8.3 (0-17.4) 3.4 (0-12.6) 0.0011
Parabasal layer 1.2 (0-7.4) 1.1 (0-7.2) 0.7348
Spinous layer 0.0 (0-1.1) 0.0 (0-6.0) 0.0781
Keratin layer 0.0 (0-0) 0.0 (0-0) -
Table 3: Median Quickscore in OLP and OLR groups. Range were presented inside parenthesis.
*Mann Whitney test; OLP (R):  oral lichen plannus - red forms; OLL :oral lichenoid lesion
regation, authors have suggested that histopathological 
features such as strict band-like infiltration, atrophic 
epithelium, saw toothed rete ridges, and Max Joseph 
space were more frequently seen in OLP than OLL. 
Conversely, lip involvement, deep connective tissue 
infiltration, and hyperparakeratosis were described as 
reliable features for the diagnosis of OLL (1, 22). 
Several different methods have been proposed to distin-
guish OLL from OLP (1-4,22-27). Jahanshahi, Ghalay-
ani and Maleki have suggested that the number of de-
granulated mast cells and greater epithelium thickness 
were more frequently seen in OLL than in OLP (23). 
Reddy et al. also described an increased number of 
degranulated mast cells in OLL, when compared with 
OLP (24). Moreover, they also described an increase in 
the number of eosinophil and capillaries in OLL than in 
OLP and normal mucosa (26). 
Arreza and collaborators (2014) reported higher expres-
sion of COX-2 in OLP when compared with OLL (25). 
Subsequently, Batu et al., (2016), suggested an increased 
prolidase activity and oxidative stress and imbalance in 
the antioxidant defense system in biological fluids of pa-
tients with OLP- and OLL-affected patients when com-
pared with the healthy subjects (26). However, OLP and 
OLL patients revealed almost similar prolidase activity 
and oxidative stress levels (28). Rodrigues and collabo-
rators (2017), proposed that the loss of heterozygosity 
in chromosomes 9p (D9S157, D9S162, D9S171), 11q 
(D11S1369), and 17p (TP53, AFM238WF2) occurred 
more frequently in OLL than in OLP (27). Our findings 
disclosure a weaker MT staining in OLL, when com-
pared to OLP. More studies should be done with larger 
casuistries to validate these discoveries on a wider scale.
As cited above, many clinical, histopathological, im-
munological and genetic criteria for differentiating 
OLP and OLL has been proposed in literature; however, 
there is currently no established cutoff to facilitate their 
segregation (1-4,22-27). Furthermore, since most of the 
described information relies on observational studies, 
such data must be taken with care because of inherent 
biases. Since there are few studies involving markers 
that facilitate the differential diagnosis between the 
OLP and OLL cases, prospective studies with stronger 
evidence levels are still needed to better understand the 
pathogenesis and the trustworthy segregational markers 
of theses lesions. 
In conclusion, the presented results show that differ-
ences in MT expression were linked with OLP and OLL 
etiopathogenesis and clinical appearance. Our data 
could not support any further clinical implications for 
the use of MT as a tool in the diagnosis and manage-
ment of these lesions. Further studies are still necessary 
to elucidate this topic. In the future, prospective blind 
controlled trials will answer if MT immune tagging has 
a real potential to be an OLP diagnosis marker, with 
prognostic value. 
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